Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Nov;80(5):1217–1224. doi: 10.1172/JCI113195

Possible role of anti-idiotypic antibodies in the induction of tumor immunity.

R C Kennedy 1, E M Zhou 1, R E Lanford 1, T C Chanh 1, C A Bona 1
PMCID: PMC442373  PMID: 2824557

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Martin R. G., Chang C., Mora P. T., Livingston D. M. Nuclear preparations of SV40-transformed cells contain tumor-specific transplantation antigen activity. Virology. 1977 Jan;76(1):420–425. doi: 10.1016/0042-6822(77)90314-2. [DOI] [PubMed] [Google Scholar]
  2. Basham T. Y., Kaminski M. S., Kitamura K., Levy R., Merigan T. C. Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma. J Immunol. 1986 Nov 1;137(9):3019–3024. [PubMed] [Google Scholar]
  3. Bona C. A., Victor-Kobrin C., Manheimer A. J., Bellon B., Rubinstein L. J. Regulatory arms of the immune network. Immunol Rev. 1984 Jun;79:25–44. doi: 10.1111/j.1600-065x.1984.tb00485.x. [DOI] [PubMed] [Google Scholar]
  4. Butel J. S., Tevethia S. S., Melnick J. L. Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res. 1972;15:1–55. doi: 10.1016/s0065-230x(08)60371-1. [DOI] [PubMed] [Google Scholar]
  5. Chang C., Martin R. G., Livingston D. M., Luborsky S. W., Hu C. P., Mora P. T. Relationship between T-antigen and tumor-specific transplantation antigen in simian virus 40-transformed cells. J Virol. 1979 Jan;29(1):69–75. doi: 10.1128/jvi.29.1.69-75.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Deppert W., Hanke K., Henning R. Simian virus 40 T-antigen-related cell surface antigen: serological demonstration on simian virus 40-transformed monolayer cells in situ. J Virol. 1980 Aug;35(2):505–518. doi: 10.1128/jvi.35.2.505-518.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dreesman G. R., Kennedy R. C. Anti-idiotypic antibodies: implications of internal image-based vaccines for infectious diseases. J Infect Dis. 1985 May;151(5):761–765. doi: 10.1093/infdis/151.5.761. [DOI] [PubMed] [Google Scholar]
  8. Dunn P. L., Johnson C. A., Styles J. M., Pease S. S., Dean C. J. Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge. Immunology. 1987 Feb;60(2):181–186. [PMC free article] [PubMed] [Google Scholar]
  9. Ertl H. C., Finberg R. W. Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone. Proc Natl Acad Sci U S A. 1984 May;81(9):2850–2854. doi: 10.1073/pnas.81.9.2850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ertl H. C., Homans E., Tournas S., Finberg R. W. Sendai virus-specific T cell clones. V. Induction of a virus-specific response by antiidiotypic antibodies directed against a T helper cell clone. J Exp Med. 1984 Jun 1;159(6):1778–1783. doi: 10.1084/jem.159.6.1778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Flood P. M., Kripke M. L., Rowley D. A., Schreiber H. Suppression of tumor rejection by autologous anti-idiotypic immunity. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2209–2213. doi: 10.1073/pnas.77.4.2209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Flyer D. C., Tevethia S. S. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VIII. Retention of SV40 TrAg sites on purified SV40 large T antigen following denaturation with sodium dodecyl sulfate. Virology. 1982 Feb;117(1):267–270. doi: 10.1016/0042-6822(82)90527-x. [DOI] [PubMed] [Google Scholar]
  13. Gell P. G., Moss P. A. Production of cell-mediated immune response to herpes simplex virus by immunization with anti-idiotypic heteroantisera. J Gen Virol. 1985 Aug;66(Pt 8):1801–1804. doi: 10.1099/0022-1317-66-8-1801. [DOI] [PubMed] [Google Scholar]
  14. Gorczynski R. M., Kennedy M., Polidoulis I., Price G. B. Altered tumor growth in vivo after immunization of mice with antitumor antibodies. Cancer Res. 1984 Aug;44(8):3291–3298. [PubMed] [Google Scholar]
  15. Hamblin T. J., Abdul-Ahad A. K., Gordon J., Stevenson F. K., Stevenson G. T. Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces. Br J Cancer. 1980 Oct;42(4):495–502. doi: 10.1038/bjc.1980.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hamblin T. J., Cattan A. R., Glennie M. J., MacKenzie M. R., Stevenson F. K., Watts H. F., Stevenson G. T. Initial experience in treating human lymphoma with a chimeric univalent derivative of monoclonal anti-idiotype antibody. Blood. 1987 Mar;69(3):790–797. [PubMed] [Google Scholar]
  17. Herlyn D., Ross A. H., Koprowski H. Anti-idiotypic antibodies bear the internal image of a human tumor antigen. Science. 1986 Apr 4;232(4746):100–102. doi: 10.1126/science.3952496. [DOI] [PubMed] [Google Scholar]
  18. Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
  19. Kaminski M. S., Kitamura K., Maloney D. G., Campbell M. J., Levy R. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J Immunol. 1986 Feb 1;136(3):1123–1130. [PubMed] [Google Scholar]
  20. Kaufmann S. H., Eichmann K., Müller I., Wrazel L. J. Vaccination against the intracellular bacterium Listeria monocytogenes with a clonotypic antiserum. J Immunol. 1985 Jun;134(6):4123–4127. [PubMed] [Google Scholar]
  21. Kennedy R. C., Adler-Storthz K., Henkel R. D., Sanchez Y., Melnick J. L., Dreesman G. R. Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science. 1983 Aug 26;221(4613):853–855. doi: 10.1126/science.6603657. [DOI] [PubMed] [Google Scholar]
  22. Kennedy R. C., Dreesman G. R., Butel J. S., Lanford R. E. Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med. 1985 Jun 1;161(6):1432–1449. doi: 10.1084/jem.161.6.1432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kennedy R. C., Dreesman G. R. Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype. J Exp Med. 1984 Mar 1;159(3):655–665. doi: 10.1084/jem.159.3.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kennedy R. C., Eichberg J. W., Lanford R. E., Dreesman G. R. Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science. 1986 Apr 11;232(4747):220–223. doi: 10.1126/science.3952505. [DOI] [PubMed] [Google Scholar]
  25. Kennedy R. C. Idiotype networks in hepatitis B virus infections. Curr Top Microbiol Immunol. 1985;119:1–13. doi: 10.1007/978-3-642-70675-2_1. [DOI] [PubMed] [Google Scholar]
  26. Kennedy R. C., Sparrow J. T., Sanchez Y., Melnick J. L., Dreesman G. R. Enhancement of viral hepatitis B antibody (Anti-HBs) response to a synthetic cyclic peptide by priming with anti-idiotype antibodies. Virology. 1984 Jul 15;136(1):247–252. doi: 10.1016/0042-6822(84)90264-2. [DOI] [PubMed] [Google Scholar]
  27. Kodama K., Ghanta V. K., Hiramoto R. N., Stohrer R. C., Kearney J. F. In vitro effect of monoclonal anti-idiotype antibodies (anti-M104E) on MOPC 104E myeloma cells. Cancer Res. 1986 Mar;46(3):1250–1254. [PubMed] [Google Scholar]
  28. Koprowski H., Herlyn D., Lubeck M., DeFreitas E., Sears H. F. Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient? Proc Natl Acad Sci U S A. 1984 Jan;81(1):216–219. doi: 10.1073/pnas.81.1.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Krolick K. A., Isakson P. C., Uhr J. W., Vitetta E. S. BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor. Immunol Rev. 1979;48:81–106. doi: 10.1111/j.1600-065x.1979.tb00299.x. [DOI] [PubMed] [Google Scholar]
  30. Kunkel H. G., Mannik M., Williams R. C. Individual Antigenic Specificity of Isolated Antibodies. Science. 1963 Jun 14;140(3572):1218–1219. doi: 10.1126/science.140.3572.1218. [DOI] [PubMed] [Google Scholar]
  31. Lanford R. E., Butel J. S. Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology. 1979 Sep;97(2):295–306. doi: 10.1016/0042-6822(79)90341-6. [DOI] [PubMed] [Google Scholar]
  32. Luborsky S. W., Chang C., Pancake S. J., Mora P. T. Comparative behavior of simian virus 40 T-antigen and of tumor-specific surface and transplantation antigens during partial purification. Cancer Res. 1978 Aug;38(8):2367–2371. [PubMed] [Google Scholar]
  33. McNamara M. K., Ward R. E., Kohler H. Monoclonal idiotope vaccine against Streptococcus pneumoniae infection. Science. 1984 Dec 14;226(4680):1325–1326. doi: 10.1126/science.6505692. [DOI] [PubMed] [Google Scholar]
  34. Meeker T. C., Lowder J., Maloney D. G., Miller R. A., Thielemans K., Warnke R., Levy R. A clinical trial of anti-idiotype therapy for B cell malignancy. Blood. 1985 Jun;65(6):1349–1363. [PubMed] [Google Scholar]
  35. Meeker T., Lowder J., Cleary M. L., Stewart S., Warnke R., Sklar J., Levy R. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N Engl J Med. 1985 Jun 27;312(26):1658–1665. doi: 10.1056/NEJM198506273122602. [DOI] [PubMed] [Google Scholar]
  36. Miller R. A., Lowder J., Meeker T. C., Brown S., Levy R. Anti-idiotypes in B-cell tumor therapy. NCI Monogr. 1987;(3):131–134. [PubMed] [Google Scholar]
  37. Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982 Mar 4;306(9):517–522. doi: 10.1056/NEJM198203043060906. [DOI] [PubMed] [Google Scholar]
  38. Nepom G. T., Nelson K. A., Holbeck S. L., Hellström I., Hellström K. E. Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice. Proc Natl Acad Sci U S A. 1984 May;81(9):2864–2867. doi: 10.1073/pnas.81.9.2864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nisonoff A., Lamoyi E. Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production. Clin Immunol Immunopathol. 1981 Dec;21(3):397–406. doi: 10.1016/0090-1229(81)90228-2. [DOI] [PubMed] [Google Scholar]
  40. OUDIN J., MICHEL M. [A new allotype form of rabbit serum gamma-globulins, apparently associated with antibody function and specificity]. C R Hebd Seances Acad Sci. 1963 Jul 17;257:805–808. [PubMed] [Google Scholar]
  41. RAPP F., BUTEL J. S., MELNICK J. L. VIRUS-INDUCED INTRANUCLEAR ANTIGEN IN CELLS TRANSFORMED BY PAPOVAVIRUS SV40. Proc Soc Exp Biol Med. 1964 Aug-Sep;116:1131–1135. doi: 10.3181/00379727-116-29472. [DOI] [PubMed] [Google Scholar]
  42. Raffeld M., Neckers L., Longo D. L., Cossman J. Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype. N Engl J Med. 1985 Jun 27;312(26):1653–1658. doi: 10.1056/NEJM198506273122601. [DOI] [PubMed] [Google Scholar]
  43. Rankin E. M., Hekman A., Hardeman M. R., Hoefnagel C. A. Dynamic studies of lymphocytes labelled with indium-111 during and after treatment with monoclonal anti-idiotype antibody in advanced B cell lymphoma. Br Med J (Clin Res Ed) 1984 Oct 27;289(6452):1097–1100. doi: 10.1136/bmj.289.6452.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Rankin E. M., Hekman A., Somers R., ten Bokkel Huinink W. Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodies. Blood. 1985 Jun;65(6):1373–1381. [PubMed] [Google Scholar]
  45. Raychaudhuri S., Saeki Y., Fuji H., Kohler H. Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen. J Immunol. 1986 Sep 1;137(5):1743–1749. [PubMed] [Google Scholar]
  46. Reagan K. J., Wunner W. H., Wiktor T. J., Koprowski H. Anti-idiotypic antibodies induce neutralizing antibodies to rabies virus glycoprotein. J Virol. 1983 Dec;48(3):660–666. doi: 10.1128/jvi.48.3.660-666.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Ritz J., Pesando J. M., Notis-McConarty J., Schlossman S. F. Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro. J Immunol. 1980 Oct;125(4):1506–1514. [PubMed] [Google Scholar]
  48. Rodkey L. S. Autoregulation of immune responses via idiotype network interactions. Microbiol Rev. 1980 Dec;44(4):631–659. doi: 10.1128/mr.44.4.631-659.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sacks D. L., Esser K. M., Sher A. Immunization of mice against African trypanosomiasis using anti-idiotypic antibodies. J Exp Med. 1982 Apr 1;155(4):1108–1119. doi: 10.1084/jem.155.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Sears H. F., Herlyn D., Steplewski Z., Koprowski H. Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma. Cancer Res. 1985 Nov;45(11 Pt 2):5910–5913. [PubMed] [Google Scholar]
  51. Sharpe A. H., Gaulton G. N., McDade K. K., Fields B. N., Greene M. I. Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med. 1984 Oct 1;160(4):1195–1205. doi: 10.1084/jem.160.4.1195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Sklar J., Cleary M. L., Thielemans K., Gralow J., Warnke R., Levy R. Biclonal B-cell lymphoma. N Engl J Med. 1984 Jul 5;311(1):20–27. doi: 10.1056/NEJM198407053110104. [DOI] [PubMed] [Google Scholar]
  53. Soule H. R., Butel J. S. Subcellular Localization of simian virus 40 large tumor antigen. J Virol. 1979 May;30(2):523–532. doi: 10.1128/jvi.30.2.523-532.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Soule H. R., Lanford R. E., Butel J. S. Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen. J Virol. 1980 Feb;33(2):887–901. doi: 10.1128/jvi.33.2.887-901.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Stein K. E., Söderström T. Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice. J Exp Med. 1984 Oct 1;160(4):1001–1011. doi: 10.1084/jem.160.4.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Stevenson F. K., Wrightham M., Glennie M. J., Jones D. B., Cattan A. R., Feizi T., Hamblin T. J., Stevenson G. T. Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. Blood. 1986 Aug;68(2):430–436. [PubMed] [Google Scholar]
  57. Stevenson G. T., Stevenson F. K. Treatment of lymphoid tumors with anti-idiotype antibodies. Springer Semin Immunopathol. 1983;6(1):99–115. doi: 10.1007/BF01857369. [DOI] [PubMed] [Google Scholar]
  58. Tilkin A. F., Schaaf-Lafontaine N., Van Acker A., Boccadoro M., Urbain J. Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cells. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1809–1812. doi: 10.1073/pnas.78.3.1809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Uytdehaag F. G., Osterhaus A. D. Induction of neutralizing antibody in mice against poliovirus type II with monoclonal anti-idiotypic antibody. J Immunol. 1985 Feb;134(2):1225–1229. [PubMed] [Google Scholar]
  60. Victor-Kobrin C., Bonilla F. A., Bellon B., Bona C. A. Immunochemical and molecular characterization of regulatory idiotopes expressed by monoclonal antibodies exhibiting or lacking beta 2-6 fructosan binding activity. J Exp Med. 1985 Aug 1;162(2):647–662. doi: 10.1084/jem.162.2.647. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES